In oxaliplatin-induced neuropathic pain, the down-regulation of Kv2.2 potassium channels in the somatosensory cortex correlates with increased neuronal and cortical excitability (Thibault et al., 2012). The gene discussed is KCNB2; the disease is neuropathic pain.